{ "tag": [ "compiled" ], "id": "ocds-h6vhtk-0775bc-2026-09-18T15:46:32+01:00", "date": "2026-09-18T15:46:32+01:00", "ocid": "ocds-h6vhtk-0775bc", "initiationType": "tender", "parties": [ { "id": "GB-PPON-PVVQ-6113-CJWD", "name": "Healthcare Quality Improvement Partnership", "identifier": { "scheme": "GB-PPON", "id": "PVVQ-6113-CJWD" }, "address": { "streetAddress": "c/o Buzzacott LLP", "locality": "London", "postalCode": "EC2V 6DL", "country": "GB", "countryName": "United Kingdom", "region": "UKI31" }, "contactPoint": { "name": "Judith Hughes", "email": "procurement@hqip.org.uk" }, "roles": [ "buyer" ], "details": { "classifications": [ { "scheme": "UK_CA_TYPE", "id": "publicAuthoritySubCentralGovernment", "description": "Public authority - sub-central government" } ] } } ], "buyer": { "id": "GB-PPON-PVVQ-6113-CJWD", "name": "Healthcare Quality Improvement Partnership" }, "tender": { "id": "1025879250", "legalBasis": { "id": "2023/54", "scheme": "UKPGA", "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents" }, "title": "National Infection and Sepsis Audit - Acute NHS settings", "description": "The contract for the Infection and Sepsis Audit - Acute care settings (NISA-Acute) will initially be delivered for NHS-funded care in England and Wales for a period of three years, at a maximum total budget of up to PS 1,146,300.00 excl VAT and PS1,375,560.00 with VAT. Bids exceeding these limits will be rejected. All pricing submissions must be in regard to this 'core' value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of PS 1,146,300.00 excl VAT and PS1,375,560.00 with VAT. The maximum budget 'core' value excludes the potential two year extension and aspirational intent as described in section 14.3 of Annex A - Service Specification. Please note, there is no commitment by the Authority at this stage to include any of the below aspirational intent. Taking this aspirational intent into account, including the possibility that a contract extension may be offered for an additional 24 months, the potential ceiling value is PS8,988,606.00 GBP including VAT. This is a new national clinical audit for severe infection and sepsis in acute NHS hospital settings. The aim is to provide benchmarked infection and sepsis care data to identify variation and drive improvement over time. Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. While it is an unusual complication of developing an infection, it can be triggered by any infection. When people die from an infection, it is most commonly due to sepsis. Sepsis is complex and hard to diagnose, with no single test and symptoms that overlap with other conditions (NHS England Modern Service Framework, 2026) Severe infections may lead to the development of sepsis, particularly in at-risk groups, and are one of the most common reasons for emergency admission to hospital. Both infection and sepsis are major causes of morbidity and mortality in the UK, and costly to the NHS and wider economy: In 2025 there were over 23,000 deaths involving sepsis (Office for National Statistics). Patients and carers who we engaged with as part of specification development told us of long-term impacts that some sepsis survivors experience, from reduced mobility and cognitive difficulties, to loss of limbs or vision impairments. Each year, the NHS in England spends over PS1billion on sepsis care, and over PS6.5billion on infection care. Wider economic costs are estimated at PS10-15billion annually (York Health Economics Consortium, 2017). 1,300 clinical negligence claims were made regarding sepsis from 2020/21 to 2024/25, costing PS65.3m in litigation. Most claims relate to delays and failures in treatment and diagnosis. Several major healthcare initiatives have been launched to help improve care related to sepsis and severe infection, including: NHS England's sepsis Modern Service Framework (MSF), which aims to reduce death, life-threatening complications and long-term impact from sepsis and severe infection by at least 25% by 2035, as well as reducing health inequalities (published July 2026). NHS England's National Improvement Programme for 'Optimising the acute management of sepsis' (as part of the MSF activities). The National Patient Safety Plan for NHS Wales 2026-2031, which includes sepsis care. The UK Anti-Microbial Resistance (AMR) National Action Plan, which pledges to strengthen infection prevention and control (IPC) and antimicrobial stewardship (AMS) in health and social care settings New NICE guidelines for recognition, diagnosis and early management of suspected sepsis, published in November 2025 (NG253-NG255) Establishing the NISA-Acute audit is a key ambition of the NHS England sepsis MSF, and the audit will be expected to align closely with all the initiatives listed above. The audit funders have selected 'early stages of care' as the initial priority for this audit because this is a critical point for effective severe infection management and the swift identification and treatment of sepsis. Prompt, effective treatment is vital to improving outcomes, and both Prevention of Future Death (PFD) reports and Health Services Safety Investigations Body (HSSIB) investigations have highlighted opportunities to improve care in this area.", "status": "active", "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "85100000", "description": "Health services" } ], "deliveryAddresses": [ { "region": "UK", "country": "GB", "countryName": "United Kingdom" } ], "relatedLot": "1" } ], "value": { "amountGross": 8988606, "amount": 7490505, "currency": "GBP" }, "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "mainProcurementCategory": "services", "aboveThreshold": true, "submissionMethodDetails": "https://www.delta-esourcing.com/", "submissionTerms": { "electronicSubmissionPolicy": "allowed", "languages": [ "en" ] }, "tenderPeriod": { "endDate": "2026-10-27T12:00:00+00:00" }, "enquiryPeriod": { "endDate": "2026-10-12T12:00:00+01:00" }, "awardPeriod": { "endDate": "2027-01-14T23:59:59+00:00" }, "lots": [ { "id": "1", "status": "active", "value": { "amountGross": 8988606, "amount": 7490505, "currency": "GBP" }, "awardCriteria": { "criteria": [ { "type": "quality", "name": "LEADERSHIP", "description": "See ITT", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "ENGAGING AND INVOLVING PATIENTS, CARERS AND THE PUBLIC", "description": "See ITT", "numbers": [ { "number": 8, "weight": "percentageExact" } ] }, { "type": "quality", "name": "SUPPORTING HEALTHCARE QUALITY IMPROVEMENT", "description": "See ITT", "numbers": [ { "number": 8, "weight": "percentageExact" } ] }, { "type": "quality", "name": "HEALTHCARE PROVIDER ENGAGEMENT, PARTICIPATION AND SUPPORT", "description": "See ITT", "numbers": [ { "number": 8, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA ACQUISITION STRATEGY AND BURDEN", "description": "See ITT", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "INFORMATION GOVERNANCE", "description": "See ITT", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA QUALITY ANALYSIS", "description": "See ITT", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "USES OF THE DATA", "description": "See ITT", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "PROGRAMME GOVERNANCE AND DELIVERY PLAN", "description": "See ITT", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "RISK MANAGEMENT", "description": "See ITT", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "price", "name": "COST & ALLOCATION OF BUDGET", "description": "See ITT", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "SOCIAL VALUE", "description": "See ITT", "numbers": [ { "number": 10, "weight": "percentageExact" } ] } ] }, "suitability": { "sme": true, "vcse": true }, "contractPeriod": { "startDate": "2027-04-01T00:00:00+01:00", "endDate": "2030-03-30T23:59:59+00:00", "maxExtentDate": "2032-03-30T23:59:59+01:00" }, "hasRenewal": true, "renewal": { "description": "Up to 2 years extension. A 5 year contract in total" } } ], "documents": [ { "id": "conflictOfInterest", "documentType": "conflictOfInterest", "description": "Not published" }, { "id": "088832-2026", "documentType": "tenderNotice", "noticeType": "UK4", "description": "Tender notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/088832-2026", "datePublished": "2026-09-18T15:46:32+01:00", "format": "text/html" } ], "contractTerms": { "financialTerms": "Payment will be made quarterly in arrears as described in the provider terms (Annex B). Disputed invoices will be dealt with as described in the provider terms (Annex B)" }, "riskDetails": "Full descriptive details of these measures, as well as the mechanisms for invoking them can be found in section 14.3 of Annex A - Service Specification. All figures are inclusive of VAT: 1. Up to 24-month extension that mirrors the NCAPOP headline contract (Please refer to Annex J - NHSE_HQIP NCAPOP Contract REDACTED) - up to PS917,040.00 2. Expansion of the scope of the NISA-Acute audit and/or addition of further workstreams, e.g. to cover more patients or other aspects of patient care (the list below is not intended to be exhaustive)up to PS2,1600,000.00 3. Addition of patient reported outcome measure (PROM) or patient reported experience measure (PREM) Up to PS600,000.00 4. Transition to different models of data collection/outputs &/or operational methods/processes for the audit. This may include implementing new ways of working where opportunities emerge to leverage artificial intelligence tools to drive efficiency and reduce burden up to PS631,080.00. 5. Extending specific service coverage to include privately funded care up to PS360,000.00 6. Additions or enhancements to the service delivery of the project up to PS1,200,000.00 7.Additional quality improvement initiatives either related to or linked with the project up to PS720,000.00" }, "language": "en" }